Vladimir Lj Lazarevic

27PUBLICATIONS
127CO-AUTHORS
Haematological tumoursHaematologyGene expression (incl. microarray and other genome-wide approaches)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 18, 2026
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

|Aug 07, 2026
Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases.

|Jul 08, 2026
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.

|Nov 25, 2025
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

Henrik Lilljebjörn, Pablo Peña-Martínez, Hanna Thorsson

|Oct 03, 2025
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Carl Sandén, Niklas Landberg, Pablo Peña-Martínez

|Jul 24, 2025
Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML-A Population-Based Study.

Markus Liew-Littorin, Linn Deleskog-Spångberg, Stefan Deneberg

Pageof 5

Frequent Collaborators

6 joint publications

Niklas Landberg

5 joint publications

Henrik Lilljebjörn

5 joint publications

Christina Orsmark-Pietras

4 joint publications

Anna Robelius